Milad Alucozai

Milad Alucozai is a co-founder of Revalia Bio and the Wyss Institute at Harvard University, where Milad also co-hosts the Code to Cure Series. As the first investor and Board Member at Seqera Labs, Milad contributes to advancing innovative solutions in biotechnology. Additionally, Milad serves as a Visiting Scientist and Senior Advisor at the Indiana Biosciences Research Institute and holds the position of Senior Advisor at the 16 Tech Innovation District. Milad's academic background includes studies as a Visiting Scholar at Harvard University and education at The Johns Hopkins University School of Medicine.